돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 644생성일: 2026년 10월 23일

1-Bromo-4-iodobenzene → 2-(4-Bromophenyl)-1,3-dihydroisoindole

https://huagongshe.com/ko/reaction/644

반응식

참여 물질

역할이름HCID투입량
반응물1-Bromo-4-iodobenzeneHCID 11522—
반응물IsoindolineHCID 422478—
시약Sodium t-butoxideHCID 23676156—
촉매1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
촉매Palladium (II) acetateHCID 4144353—
용매TolueneHCID 1140—
생성물2-(4-Bromophenyl)-1,3-dihydroisoindoleHCID 371387848.3%

반응 조건

온도100 °C

반응 단계

palladium(II) acetate (0.112 g, 0.50 mmol) and XANTPHOS (0.288 g, 0.50 mmol) were added to a degassed solution of isoindoline (0.566 ml, 4.98 mmol), 1-bromo-4-iodobenzene (1.41 g, 4.98 mmol) and SODIUM TERT-BUTOXIDE (1.197 g, 12.46 mmol) in toluene (49.3 ml) under nitrogen. The resulting solution was stirred at 100 °C for 18 hours. The reaction mixture was allowed to cool to RT and was partitioned between EtOAc and H2O, filtered and the organic layer separated and dried over MgSO4, filtered and evaporated to dryness to give crude product. The crude product preabsorbed onto SiO2 and was purified by flash silica (40g, grace) chromatography, elution gradient 0 to 10% DCM in heptane. Pure fractions were evaporated to dryness to afford 2-(4-bromophenyl)isoindoline (0.660 g, 48.3 %) as an orange solid.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-be64b42a88614cc79bed55017a7f5289
출처 메모750 AstraZeneca ELN dataset